Related Experiment Video

Updated: Aug 11, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Multiply-resistant pneumococcus: therapeutic problems in the management of serious infections

P D Lister1

  • 1Department of Medical Microbiology, Creighton University School of Medicine, Omaha, Nebraska 68178, USA.

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|January 1, 1995
PubMed

Insights

Penicillin-resistant pneumococci are a growing global threat, often resisting multiple antibiotics. This necessitates urgent development of new treatments and judicious antibiotic use to combat rising antimicrobial resistance.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Clinical Therapeutics

Background:

  • Penicillin-resistant *Streptococcus pneumoniae* (PRSP) presents a significant clinical challenge.
  • The prevalence and geographic spread of PRSP have increased dramatically since the late 1960s.
  • PRSP strains are increasingly resistant to multiple antibiotic classes, complicating treatment options.

Purpose of the Study:

  • To highlight the increasing threat of penicillin-resistant pneumococci.
  • To emphasize the challenge posed by multidrug-resistant strains.
  • To underscore the need for novel therapeutic strategies and responsible antibiotic stewardship.

Main Methods:

  • Literature review on the epidemiology and resistance patterns of *Streptococcus pneumoniae*.
  • Analysis of clinical implications of multidrug-resistant strains.
  • Discussion of current and future treatment challenges.

Main Results:

  • Penicillin resistance in pneumococci is widespread globally, exceeding 60% in some regions.
  • Multidrug resistance, including to cephalosporins and non-beta-lactam agents, is a major concern.
  • Limited therapeutic options exist for life-threatening infections caused by these resistant strains.

Conclusions:

  • Continued emergence of multidrug-resistant *Streptococcus pneumoniae* necessitates urgent research into new, well-tolerated treatments.
  • Judicious antibiotic use and addressing the selection pressure of antibiotics are critical to mitigate future resistance.
  • Effective control strategies are essential to manage the growing public health threat of resistant pneumococcal infections.

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...